{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:19:28Z","timestamp":1768270768742,"version":"3.49.0"},"reference-count":222,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1986,4,1]],"date-time":"1986-04-01T00:00:00Z","timestamp":512697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Toxicology"],"published-print":{"date-parts":[[1986,4]]},"DOI":"10.1007\/bf03259832","type":"journal-article","created":{"date-parts":[[2016,2,7]],"date-time":"2016-02-07T20:29:52Z","timestamp":1454876992000},"page":"122-141","source":"Crossref","is-referenced-by-count":59,"title":["Adverse Reactions with Angiotensin Converting Enzyme (ACE) Inhibitors"],"prefix":"10.1007","volume":"1","author":[{"given":"Robert","family":"DiBianco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"BF03259832_CR1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0002-8703(83)90702-0","volume":"106","author":"I Abe","year":"1983","unstructured":"Abe I, Kawasaki T, Kawazoe N. Acute electrocardiographic effects of captopril in the initial treatment of malignant or severe hypertension. American Heart Journal 106: 558\u2013562, 1983","journal-title":"American Heart Journal"},{"key":"BF03259832_CR2","first-page":"1314","volume":"43","author":"WB Abrams","year":"1984","unstructured":"Abrams WB, Davies RD, Ferguson RK. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy. Federation Proceedings 43: 1314\u20131321, 1984","journal-title":"Federation Proceedings"},{"key":"BF03259832_CR3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0002-9343(85)90530-3","volume":"79","author":"A AI Al-Mufti","year":"1985","unstructured":"Al-Mufti, Arieff AI. Captopril-induced hyponatremia with irreversible neurologic damage. American Journal of Medicine 79: 769\u2013772, 1985","journal-title":"American Journal of Medicine"},{"key":"BF03259832_CR4","first-page":"150","volume":"1","author":"FW Amman","year":"1980","unstructured":"Amman FW, Buhler FR, Conen D, et al. Captopril-associated agranulocytosis. Lancet 1: 150, 1980","journal-title":"Lancet"},{"key":"BF03259832_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pa.22.040182.000421","volume":"22","author":"MJ Antonaccio","year":"1982","unstructured":"Antonaccio MJ. Angiotensin converting enzyme (ACE) inhibitors. Annual Review of Pharmacology and Toxicology 22: 57\u201387, 1982","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"BF03259832_CR6","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/0002-9149(82)90361-7","volume":"49","author":"AB Atkinson","year":"1982","unstructured":"Atkinson AB, Brown JJ, Cumming AM, Fraser R, Lever AF, et al. Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome. American Journal of Cardiology 49: 1460\u20131466, 1982","journal-title":"American Journal of Cardiology"},{"key":"BF03259832_CR7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(80)92912-8","volume":"2","author":"AB Atkinson","year":"1980","unstructured":"Atkinson AB, Brown JJ, Lever AF, et al. Neurological dysfunction in two patients receiving captopril and cimetidine. Lancet 2: 36\u201337, 1980","journal-title":"Lancet"},{"key":"BF03259832_CR8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(80)90001-X","volume":"2","author":"AB Atkinson","year":"1980","unstructured":"Atkinson AB, Brown JJ, Lever AF, McAreavey D, Robertson JIS. Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet 2: 105\u2013107, 1980","journal-title":"Lancet"},{"key":"BF03259832_CR9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(79)92186-X","volume":"2","author":"AB Atkinson","year":"1979","unstructured":"Atkinson AB, Robertson JIS. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet 2: 836\u2013839, 1979","journal-title":"Lancet"},{"key":"BF03259832_CR10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/01.HYP.1.3.274","volume":"1","author":"SA Atlas","year":"1979","unstructured":"Atlas SA, Case DB, Sealey JE, Laragh JH, McKinnstry DN. Interruption of the renin angiotensin system in hypertensive patients by captopril induces sustained reduction in aldoster-one secretion, potassium retention and natriuresis. Hypertension 1: 274\u2013280, 1979","journal-title":"Hypertension"},{"key":"BF03259832_CR11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0002-8703(82)90332-5","volume":"103","author":"NA Awan","year":"1982","unstructured":"Awan NA, Amsterdam EA, Hermanovich J, Bommer WJ, Needham KE, et al. Long-term hemodynamic and clinical efficacy of captopni therapy in ambulatory management of severe chronic congestive heart failure. American Heart Journal 103: 474\u2013479, 1982a","journal-title":"American Heart Journal"},{"key":"BF03259832_CR12","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/0002-8703(82)90055-2","volume":"104","author":"NA Awan","year":"1982","unstructured":"Awan NA, Needham KE, Lui H, Rutledge J, Amsterdam EA, Mason DT. Complementary combined captopril and terbutaline therapy in severe chronic congestive heart failure. American Heart Journal 104: 1224\u20131228, 1982b","journal-title":"American Heart Journal"},{"key":"BF03259832_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0272-6386(84)80027-X","volume":"4","author":"JH Bauer","year":"1984","unstructured":"Bauer JH, Jones LB. Comparative studies: enalapril versus hydrochlorthiazide as first step therapy for the treatment of primary hypertension. American Journal of Kidney Diseases 4: 55\u201362, 1984","journal-title":"American Journal of Kidney Diseases"},{"key":"BF03259832_CR14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.HYP.6.2_Pt_2.I193","volume":"6","author":"W Bender","year":"1984","unstructured":"Bender W, La France N, Walker WG. Mechanism of deterioration in renal function in patients with renovascular hypertension treated with enalapril. Hypertension 6: 1193\u20131197, 1984","journal-title":"Hypertension"},{"key":"BF03259832_CR15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM198302173080709","volume":"308","author":"WB Blythe","year":"1983","unstructured":"Blythe WB: Captopril and renal autoregulation. New England Journal of Medicine 308: 390\u2013391, 1983","journal-title":"New England Journal of Medicine"},{"key":"BF03259832_CR16","doi-asserted-by":"crossref","unstructured":"Boutroy MJ, de Ligney BH, Miton A. Captopril administration in pregnancy impairs fetal angiotensin converting enzyme activity and neonatal adaptation. Lancet: 935\u2013936, 1984","DOI":"10.1016\/S0140-6736(84)90695-0"},{"key":"BF03259832_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/01.HYP.1.1.39","volume":"1","author":"EL Bravo","year":"1979","unstructured":"Bravo EL, Tarazi RC. Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension 1: 39\u201346, 1979","journal-title":"Hypertension"},{"key":"BF03259832_CR18","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00005344-198507001-00002","volume":"7","author":"HR Brunner","year":"1985","unstructured":"Brunner HR, Nussberger J, Waeber B. The present molecules of converting enzyme inhibitors. Journal of Cardiovascular Pharmacology 7: S2\u201311, 1985","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"BF03259832_CR19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0140-6736(78)92703-4","volume":"2","author":"HR Brunner","year":"1978","unstructured":"Brunner HR, Waeber B, Wauters JP. Inappropriate renin secretion unmasked by captopril (SQ14,225) in hypertension of chronic renal failure. Lancet 2: 704\u2013707, 1978","journal-title":"Lancet"},{"key":"BF03259832_CR20","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/archinte.1984.00350220091020","volume":"144","author":"TG Burnakis","year":"1984","unstructured":"Burnakis TG, Mioduch HJ. Combined therapy with captopril and potassium supplementation: a potential for hyperkalemia. Archives of Internal Medicine 144: 2371\u20132372, 1984","journal-title":"Archives of Internal Medicine"},{"key":"BF03259832_CR21","doi-asserted-by":"crossref","unstructured":"Callender J, Hodsman GP, Robertson JIS. Mood changes during captopril therapy for hypertension: a doubleblind pilot study. (Abstract.) First European Meeting on Hypertension, Milan, May, 1983","DOI":"10.1161\/01.HYP.5.5_Pt_2.III90"},{"key":"BF03259832_CR22","first-page":"988","volume":"1","author":"Captopril Collaborative Study Group.","year":"1982","unstructured":"Captopril Collaborative Study Group. Does captopril cause renal damage in hypertensive patients? Lancet 1: 988\u2013990, 1982","journal-title":"Lancet"},{"key":"BF03259832_CR23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0735-1097(83)80316-7","volume":"2","author":"Captopril Multicenter Research Group.","year":"1983","unstructured":"Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Journal of the American College of Cardiology 2: 755\u2013763 1983","journal-title":"Journal of the American College of Cardiology"},{"key":"BF03259832_CR24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0033-0620(78)90025-7","volume":"21","author":"DB Case","year":"1978","unstructured":"Case DB, Atlas SA, Laragh JH, Sealey JE, Sullivan PA, et al. Clinical experience with blockade of the renin-angiotensin-aldosterone-system by an oral converting enzyme inhibitor (SQ14,225, captopril) in hypertensive patients. Progress in Cardiovascular Diseases 21: 195\u2013206, 1978","journal-title":"Progress in Cardiovascular Diseases"},{"key":"BF03259832_CR25","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/0002-9149(82)90358-7","volume":"49","author":"DB Case","year":"1982","unstructured":"Case DB, Atlas SA, Marion RM, Laragh JH. Long-term efficacy of captopril in renovascular and essential hypertension. American Journal of Cardiology 49: 1440\u20131446, 1982","journal-title":"American Journal of Cardiology"},{"key":"BF03259832_CR26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1001\/jama.1980.03310040028020","volume":"244","author":"DB Case","year":"1980","unstructured":"Case DB, Atlas SA, Mouradian JA, Fishman RA, Sherman RL, et al. Proteinuria during long-term captopril therapy. Journal of American Medical Association 244: 346\u2013349, 1980","journal-title":"Journal of American Medical Association"},{"key":"BF03259832_CR27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJM197703242961201","volume":"296","author":"DB Case","year":"1977","unstructured":"Case DB, Wallace JM, Keim HJ, Weber MA, Sealey JE, Lanagh JH. Possible role of renin in hypertension as suggested by reninsodium profiling and inhibition of the converting enzyme. New England Journal of Medicine 296: 641\u2013646, 1977","journal-title":"New England Journal of Medicine"},{"key":"BF03259832_CR28","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0140-6736(81)92535-6","volume":"1","author":"DB Case","year":"1981","unstructured":"Case DB, Whittman HH III, Laragh JH. Successful low dose captopril rechallenge following drug-induced leukopenia. Lancet 1: 1362, 1981","journal-title":"Lancet"},{"key":"BF03259832_CR29","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0002-8703(82)90042-4","volume":"104","author":"K Chatterjee","year":"1982","unstructured":"Chatterjee K, Rouleau JL, Parmley WW. Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost. American Heart Journal 104: 1137\u201346, 1982","journal-title":"American Heart Journal"},{"key":"BF03259832_CR30","first-page":"437","volume":"143","author":"GG Chrysant","year":"1983","unstructured":"Chrysant GG, Dunn M, Marples D, DeMasters K. Severe reversible azotemia from captopril therapy. American Journal of Medicine 143: 437\u2013441, 1983","journal-title":"American Journal of Medicine"},{"key":"BF03259832_CR31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archderm.1981.01650090005006","volume":"117","author":"MI Clement","year":"1981","unstructured":"Clement MI. Captopril-induced eruptions. Archives of Dermatology 117: 525\u2013526, 1981","journal-title":"Archives of Dermatology"},{"key":"BF03259832_CR32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/clpt.1982.228","volume":"32","author":"RJ Cody","year":"1982","unstructured":"Cody RJ, Schaer GL, Covit AB, Pondofino D, Williams G. Captopril kinetics in chronic congestive heart failure. Clinical Pharmacology and Therapeutics 32: 721\u2013726, 1982","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259832_CR33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1542\/peds.71.5.839","volume":"71","author":"RD Colavita","year":"1983","unstructured":"Colavita RD, Gaudlo KM, Siegel NJ. Reversible reduction in renal function during treatment with captopril. Pediatrics 71: 839\u2013840, 1983","journal-title":"Pediatrics"},{"key":"BF03259832_CR34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.1983.00350040049004","volume":"143","author":"RA Cooper","year":"1983","unstructured":"Cooper RA. Captopril-associated neutropenia. Who is at risk? Archives of Internal Medicine 143: 659\u2013660, 1983","journal-title":"Who is at risk? Archives of Internal Medicine"},{"key":"BF03259832_CR35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000183065","volume":"35","author":"P Coulie","year":"1983","unstructured":"Coulie P, De Plaen JF, de Strihou CVY. Captopril-induced acute reversible renal failure. Nephron 35: 108\u2013111, 1983","journal-title":"Nephron"},{"key":"BF03259832_CR36","first-page":"47","volume":"4","author":"G Covi","year":"1984","unstructured":"Covi G, Minuz P, Capuzzo G, Lechi C, Delva P. Reduction in the antihypertensive effect of captopril induced by prostaglandin synthetase inhibition. International Journal of Clinical Pharmacology Research 4: 47\u201352, 1984","journal-title":"International Journal of Clinical Pharmacology Research"},{"key":"BF03259832_CR37","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0002-8703(82)90043-6","volume":"104","author":"MA Creager","year":"1982","unstructured":"Creager MA, Faxon DP, Halperin JL, Melidossian CD, McCabe CH, et al. Determinants of clinical response and survival in patients with congestive heart failure treated with captopril. American Heart Journal 104: 1147\u20131154, 1982","journal-title":"American Heart Journal"},{"key":"BF03259832_CR38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(85)91239-5","volume":"1","author":"WJC Currie","year":"1985","unstructured":"Currie WJC, Cooper WD. Safety of angiotensin-converting enzyme inhibitors. Lancet 1: 580\u2013581, 1985","journal-title":"Lancet"},{"key":"BF03259832_CR39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM198302173080707","volume":"308","author":"JJ Curtis","year":"1983","unstructured":"Curtis JJ, Luke RG, Whelchel JD, Diethelm AG, Jones P, et al. Inhibition of angiotensin converting enzyme in renal transplant recipients with hypertension. New England Journal of Medicine 308: 377\u2013381, 1983","journal-title":"New England Journal of Medicine"},{"key":"BF03259832_CR40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9343(84)80055-8","volume":"77","author":"RD Davies","year":"1984","unstructured":"Davies RD, Irvin JD, Kramsch DK, Walker JF, Moncloa F. Enalapril worldwide experience. American Journal of Medicine 77: 23\u201335, 1984","journal-title":"American Journal of Medicine"},{"key":"BF03259832_CR41","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(85)91480-1","volume":"1","author":"JC Davin","year":"1985","unstructured":"Davin JC, Mahieu PR. Captopril-associated renal failure with endarteritis but not renal artery stenosis in transplant recipient. Lancet 1: 820, 1985","journal-title":"Lancet"},{"key":"BF03259832_CR42","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0735-1097(83)80233-2","volume":"2","author":"L Carlo Di","year":"1983","unstructured":"Di Carlo L, Chatterjee K, Parmley WW, Swedberg K, Aterton B, et al. Enalapril: a new angiotensin converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations. Journal of the American College of Cardiology 2: 865\u2013871, 1983","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"BF03259832_CR43","first-page":"155","volume":"1","author":"CT Dollery","year":"1983","unstructured":"Dollery CT. Safety and efficacy of enalapril: summing up the evidence. Journal of Hypertension 1 (Suppl. 1): 155\u2013157, 1983","journal-title":"Journal of Hypertension"},{"key":"BF03259832_CR44","first-page":"108","volume":"5","author":"JIM Drayer","year":"1983","unstructured":"Drayer JIM, Weber MA. Monotherapy of essential hypertension with a converting-enzyme inhibitor. Hypertension 5: 108\u2013113, 1983","journal-title":"Hypertension"},{"key":"BF03259832_CR45","unstructured":"Dreslinski GR, Jenkins AC, Tadros SS. Captopril in patients with renal disease: worldwide experience, in press, 1986"},{"key":"BF03259832_CR46","first-page":"805","volume":"60","author":"PC Duminy","year":"1981","unstructured":"Duminy PC, Burger P du T. Fetal abnormality associated with the use of captopril during pregnancy. South African Medical Journal 60: 805, 1981","journal-title":"South African Medical Journal"},{"key":"BF03259832_CR47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-100-6-777","volume":"100","author":"VJ Dzau","year":"1984","unstructured":"Dzau VJ, Hollenberg NK. Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia. Annals of Internal Medicine 100: 777\u2013782, 1984","journal-title":"Annals of Internal Medicine"},{"key":"BF03259832_CR48","first-page":"121","volume":"23","author":"VJ Dzau","year":"1983","unstructured":"Dzau VJ, Hricik DE, Browning PJ, Kopelman RI, Goorno WE, et al. Captopril-induced functional renal insufficiency in patients with bilateral renal artery stenosis or renal artery stenosis to a \u2018solitary\u2019 kidney. Kidney International 23: 121, 1983","journal-title":"Kidney International"},{"key":"BF03259832_CR49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM198402093100603","volume":"310","author":"VJ Dzau","year":"1984","unstructured":"Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, et al. Prostaglandins in severe congestive heart failure. New England Journal of Medicine 310: 347\u2013352, 1984","journal-title":"New England Journal of Medicine"},{"key":"BF03259832_CR50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(81)91998-X","volume":"1","author":"CRW Edwards","year":"1981","unstructured":"Edwards CRW, Drury P, Penketh A, Damluji SA. Successful reintroduction of captopril following neutropenia. Lancet 1: 723, 1981","journal-title":"Lancet"},{"key":"BF03259832_CR51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0140-6736(85)90975-4","volume":"1","author":"CRW Edwards","year":"1985","unstructured":"Edwards CRW, Padfield PL. Angiotensin-converting enzyme inhibitors: past, present and bright future. Lancet 1: 30\u201334, 1985","journal-title":"Lancet"},{"key":"BF03259832_CR52","doi-asserted-by":"crossref","unstructured":"Elijovisch F, Krakoff LR. Captopril-associated granulocytopenia in hypertension after transplantation. Lancet (April 26): 927\u2013928, 1980","DOI":"10.1016\/S0140-6736(80)90854-5"},{"key":"BF03259832_CR53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-9343(84)90887-8","volume":"76","author":"LS Erikson","year":"1984","unstructured":"Erikson LS, Kagedal B, Wahren J. Effects of captopril on hepatic venous pressure and blood flow in patients with liver cirrhosis. American Journal of Medicine 76: 66\u201370, 1984","journal-title":"American Journal of Medicine"},{"key":"BF03259832_CR54","first-page":"660","volume":"3","author":"AJ Erslev","year":"1982","unstructured":"Erslev AJ, Alexander JC, Caro J, Boyd RL. Hematologic side effects of captopril and associated risk factors. Cardiovascular Reviews and Reports 3: 660\u2013671, 1982","journal-title":"Cardiovascular Reviews and Reports"},{"key":"BF03259832_CR55","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/bmj.286.6365.648","volume":"286","author":"RG Fassett","year":"1983","unstructured":"Fassett RG, Walker RG, Whitworth JA, Kincaid-Smith P. Repeated renal failure with captopril. British Medical Journal 286: 648, 1983","journal-title":"British Medical Journal"},{"key":"BF03259832_CR56","doi-asserted-by":"crossref","first-page":"179S","DOI":"10.1111\/j.1365-2125.1982.tb02075.x","volume":"14","author":"DP Faxon","year":"1982","unstructured":"Faxon DP, Creager MA, Halperin JL. Regional circulatory responses to converting enzyme inhibition in congestive heart failure. British Journal of Clinical Pharmacology 14: 179S\u2013186S, 1982","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259832_CR57","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0140-6736(77)92958-0","volume":"1","author":"RK Ferguson","year":"1977","unstructured":"Ferguson RK, Turini GA, Brunner HR, Gavras H, McKinstry DN. A specific orally active inhibitor of angiotensin converting enzyme in man. Lancet 1: 775\u2013778, 1977","journal-title":"Lancet"},{"key":"BF03259832_CR58","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0002-8703(80)90730-9","volume":"99","author":"RK Ferguson","year":"1980","unstructured":"Ferguson RK, Vlasses PH, Koplin JR, Shirinian A, Burke Jr JF, et al. Captopril in severe treatment-resistant hypertension. American Heart Journal 99: 579\u2013585, 1980","journal-title":"American Heart Journal"},{"key":"BF03259832_CR59","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/0002-9343(84)90367-X","volume":"77","author":"RK Ferguson","year":"1984","unstructured":"Ferguson RK, Vlasses PH, Rotmensch HH. Clinical applications of the angiotensin converting enzyme inhibitors. American Journal of medicine 77: 690\u2013698, 1984","journal-title":"American Journal of medicine"},{"key":"BF03259832_CR60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1476-5381.1965.tb02091.x","volume":"24","author":"SH Ferreira","year":"1965","unstructured":"Ferreira SH. A bradykinin-potentiating factor (BPF) present in the venom of Bothrops Jararaca. British Journal of Pharmacology and Chemotherapy 24: 163\u2013169, 1965 auFDAapproved package insert. Capoten-R tablets; captopril tablets, September, 1984a","journal-title":"British Journal of Pharmacology and Chemotherapy"},{"key":"BF03259832_CR61","unstructured":"FDAapproved package insert. Capoten-R tablets; captopril tablets, June, 1985"},{"key":"BF03259832_CR62","unstructured":"FDACardiorenal Advisory Committee Proceedings, June 20, Bethesda, 1984b"},{"key":"BF03259832_CR63","unstructured":"FDAapproved package insert. Vasotec-R tablets; enalapril maleate, December, 1985"},{"key":"BF03259832_CR64","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(84)91581-2","volume":"2","author":"R Fiocchi","year":"1984","unstructured":"Fiocchi R, Lijnen R, Staessen J, Fagard R, Amery A. Captopril in pregnancy. Lancet 2: 1153, 1984","journal-title":"Lancet"},{"key":"BF03259832_CR65","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(81)90765-0","volume":"1","author":"T Forslund","year":"1981","unstructured":"Forslund T, Borgmastars H, Fyrquist F. Captopril associated leucopenia confirmed by rechallenge in patients with renal failure. Lancet 1: 166, 1981","journal-title":"Lancet"},{"key":"BF03259832_CR66","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archinte.1983.00350060184031","volume":"143","author":"S Fotino","year":"1983","unstructured":"Fotino S, Sporn P. Nonoliguric renal failure after captopril therapy. Archives of Internal Medicine 143: 1252\u20131253, 1983","journal-title":"Archives of Internal Medicine"},{"key":"BF03259832_CR67","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinte.1984.00350190137023","volume":"144","author":"ED Frohlich","year":"1984","unstructured":"Frohlich ED, Cooper RA, Lewis EJ. Review of the overall experience of captopril in hypertension. Archives of Internal Medicine 144: 1441\u20131444, 1984","journal-title":"Archives of Internal Medicine"},{"key":"BF03259832_CR68","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0002-9149(85)90756-8","volume":"55","author":"C Furberg","year":"1985","unstructured":"Furberg C, Yusuf S. Effect of vasodilators on survival in chronic congestive heart failure. American Journal of Cardiology 55: 1110\u20131113, 1985","journal-title":"American Journal of Cardiology"},{"key":"BF03259832_CR69","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0735-1097(83)80082-5","volume":"1","author":"H Gavras","year":"1983","unstructured":"Gavras H. Hypertension and congestive heart failure: benefits of converting enzyme inhibition (captopril). Journal of the American College of Cardiology 1: 518\u2013520, 1983","journal-title":"Journal of the American College of Cardiology"},{"key":"BF03259832_CR70","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(74)91734-6","volume":"2","author":"H Gavras","year":"1974","unstructured":"Gavras H, Brunner HR, Gavras I, et al. Hypotensive effect of angiotensin-converting enzyme inhibitor [SQ20,881] Lancet 2: 353, 1974a","journal-title":"Lancet"},{"key":"BF03259832_CR71","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM197410172911603","volume":"291","author":"H Gavras","year":"1974","unstructured":"Gavras H, Brunner HR, Laragh JH, Sealey JE, Gavras I, et al. An angiotensin-converting enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. New England Journal of Medicine 291: 817\u2013824, 1974b","journal-title":"New England Journal of Medicine"},{"key":"BF03259832_CR72","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/01.CIR.58.5.770","volume":"58","author":"H Gavras","year":"1978","unstructured":"Gavras H, Faxon DP, Berkoben J, Brunner HR, Ryan TJ. Angiotensin converting enzyme inhibition in patients with congestive heart failure. Circulation 58: 770\u2013776, 1978","journal-title":"Circulation"},{"key":"BF03259832_CR73","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7326\/0003-4819-98-4-556_2","volume":"98","author":"I Gavras","year":"1983","unstructured":"Gavras I, Gavras H. Captopril and enalapril. Annals of Internal Medicine 98: 556, 1983","journal-title":"Annals of Internal Medicine"},{"key":"BF03259832_CR74","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/0003-4819-94-1-58","volume":"94","author":"I Gavras","year":"1981","unstructured":"Gavras I, Graff LG, Rose BD, McKenna JM, Brunner HR, et al. Fatal pancytopenia associated with the use of captopril. Annals of Internal Medicine 94: 58\u201359, 1981","journal-title":"Annals of Internal Medicine"},{"key":"BF03259832_CR75","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1176\/ajp.142.12.1522-b","volume":"142","author":"MA Gillman","year":"1985","unstructured":"Gillman MA, Sandy KR. Reversal of captopril-induced psychosis with naloxone (correspondence). American Journal of Psychiatry 142: 270, 1985","journal-title":"American Journal of Psychiatry"},{"key":"BF03259832_CR76","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0090-6980(81)90068-X","volume":"22","author":"R Goldstone","year":"1981","unstructured":"Goldstone R, Martin K, Zipser R, Horton R. Evidence for a dual action of converting enzyme inhibitor on blood pressure in normal men. Prostaglandins 22: 587\u2013598, 1981","journal-title":"Prostaglandins"},{"key":"BF03259832_CR77","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.290.6475.1111","volume":"290","author":"MJ Goodfield","year":"1985","unstructured":"Goodfield MJ, Millard LG. Severe cutaneous reactions to captopril. British Medical Journal 290 (Vol. 2): 1111, 1985","journal-title":"British Medical Journal"},{"key":"BF03259832_CR78","doi-asserted-by":"crossref","unstructured":"Goodfield MJD, Millard LG, Banks DC, Morris GK. Extended use of captopril. Lancet: 517, 1984","DOI":"10.1016\/S0140-6736(84)92589-3"},{"key":"BF03259832_CR79","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(80)92860-3","volume":"2","author":"A Grossman","year":"1980","unstructured":"Grossman A, Eckland D, Price P, Edwards CRW. Captopril: reversible renal failure with severe hyperkalaemia. Lancet 2: 712, 1980","journal-title":"Lancet"},{"key":"BF03259832_CR80","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/0002-9149(82)90362-9","volume":"49","author":"J Havelka","year":"1982","unstructured":"Havelka J, Vetter H, Studer A, Greminger P, Luscher T, et al. Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension. American Journal of Cardiology 49: 1467\u20131474, 1982","journal-title":"American Journal of Cardiology"},{"key":"BF03259832_CR81","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00003495-198020060-00001","volume":"20","author":"RC Heel","year":"1980","unstructured":"Heel RC, Brogden TM, Speight TM, Avery GS. Captopril: a preliminary review of its pharmacological propereties and therapeutic efficacy. Drugs 20: 409\u2013452, 1980","journal-title":"Drugs"},{"key":"BF03259832_CR82","first-page":"525","volume":"129","author":"RA Hegele","year":"1983","unstructured":"Hegele RA. Hemolytic anemia: possible complication of captopril therapy. Canadian Medical Association Journal 129: 525\u2013526, 1983","journal-title":"Canadian Medical Association Journal"},{"key":"BF03259832_CR83","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/bmj.287.6403.1413","volume":"287","author":"GP Hodsman","year":"1983","unstructured":"Hodsman GP, Brown JJ, Cumming AM, Davies DL, East BW, et al. Enalapril in the treatment of hypertension with renal artery stenosis. British Medical Journal 287: 1413\u20131417, 1983a","journal-title":"British Medical Journal"},{"key":"BF03259832_CR84","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/bmj.286.6368.832","volume":"286","author":"GP Hodsman","year":"1983","unstructured":"Hodsman GP, Isles CG, Murray GD, Usherwood TP, Webb DJ, Robertson JIS. Factors related to first dose hypotensive effect of captopril: prediction and treatment. British Medical Journal 286: 832\u2013834, 1983b","journal-title":"British Medical Journal"},{"key":"BF03259832_CR85","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/bmj.287.6396.851","volume":"287","author":"GP Hodsman","year":"1983","unstructured":"Hodsman GP, Robertson JIS. Captopril: five years on. British Medical Journal 287: 851\u2013852, 1983","journal-title":"British Medical Journal"},{"key":"BF03259832_CR86","first-page":"269","volume":"27","author":"WHL Hoefnagels","year":"1984","unstructured":"Hoefnagels WHL, Strijk SP, Thien T. Reversible renal failure following treatment with captopril and diuretics in patients with renovascular hypertension. Netherlands Journal of Medicine 27: 269\u2013274, 1984","journal-title":"Netherlands Journal of Medicine"},{"key":"BF03259832_CR87","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0002-9149(82)90355-1","volume":"49","author":"N Hollenberg","year":"1982","unstructured":"Hollenberg N. Renal response to ACE inhibition. American Journal of Cardiology 49: 1425\u20131429, 1982a","journal-title":"American Journal of Cardiology"},{"key":"BF03259832_CR88","first-page":"426","volume":"3","author":"NK Hollenberg","year":"1982","unstructured":"Hollenberg NK. Effects of converting enzyme inhibition on renal perfusion and function. Cardiovascular Reviews and Reports 3: 426\u2013430, 1982b","journal-title":"Cardiovascular Reviews and Reports"},{"key":"BF03259832_CR89","first-page":"852","volume":"4","author":"NK Hollenberg","year":"1983","unstructured":"Hollenberg NK. Medical treatment of renovascular hypertension. Efficacy and safety of captopril in 269 patients. Cardiovascular Reviews and Reports 4: 852\u2013878, 1983","journal-title":"Efficacy and safety of captopril in 269 patients. Cardiovascular Reviews and Reports"},{"key":"BF03259832_CR90","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000166851","volume":"4","author":"H Hirakata","year":"1984","unstructured":"Hirakata H, Onoyama K, Iseki K, Kumagai H, Fujimi S, et al. Worsening of anemia induced by long-term use of captopril in hemodialysis patients. American Journal of Nephrology 4: 355\u2013360, 1984","journal-title":"American Journal of Nephrology"},{"key":"BF03259832_CR91","first-page":"673","volume":"3","author":"JW Hollifield","year":"1982","unstructured":"Hollifield JW, Moore LC, Winn SD, Marshall A, McCombs C, et al. Angiotensin converting enzyme inhibition in renovascular hypertension, Cardiovascular Reviews and Reports 3: 673\u2013676, 1982","journal-title":"Cardiovascular Reviews and Reports"},{"key":"BF03259832_CR92","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/bmj.285.6354.1538","volume":"285","author":"D Hooke","year":"1982","unstructured":"Hooke D, Walker RG, Walter NMA, D\u2019Apice AJF, Whitworth J, et al. Repeated renal failure with use of captopril in a cystinotic renal allograft recipient. British Medical Journal 285: 1538, 1982","journal-title":"British Medical Journal"},{"key":"BF03259832_CR93","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0140-6736(80)91677-3","volume":"1","author":"SJ Hoontje","year":"1980","unstructured":"Hoontje SJ, Weaning JJ, Donker AJM, The TH, Kallenberg CGM, et al. Immune-complex glomerulopathy in patients treated with captopril. Lancet 1: 1212, 1980","journal-title":"Lancet"},{"key":"BF03259832_CR94","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1001\/archinte.1983.00350100197041","volume":"143","author":"DE Hricik","year":"1983","unstructured":"Hricik DE. Reversible azotemia. Archives of Internal Medicine 143: 2013, 1983","journal-title":"Archives of Internal Medicine"},{"key":"BF03259832_CR95","doi-asserted-by":"crossref","first-page":"222","DOI":"10.7326\/0003-4819-103-2-222","volume":"103","author":"DE Hricik","year":"1985","unstructured":"Hricik DE. Captopril-induced renal insufficiency and the role of sodium balance. Annals of Internal Medicine 103: 222\u2013223, 1985","journal-title":"Annals of Internal Medicine"},{"key":"BF03259832_CR96","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM198302173080706","volume":"308","author":"DE Hricik","year":"1983","unstructured":"Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, et al. Captopril-induced functional renal insufficiency in patients with bilateral renal artery stenosis or a solitary kidney. New England Journal of Medicine 308: 373\u2013376, 1983","journal-title":"New England Journal of Medicine"},{"key":"BF03259832_CR97","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jama.1981.03310300032015","volume":"245","author":"CM Huang","year":"1981","unstructured":"Huang CM, del Greco F, Quintanilla A, Molteni A. Comparison of antihypertensive effects of captopril and propranolol in essential hypertension. Journal of the American Medical Association 245: 478\u2013482, 1981","journal-title":"Journal of the American Medical Association"},{"key":"BF03259832_CR98","first-page":"142","volume":"21","author":"HS Huang","year":"1984","unstructured":"Huang HS, Reynertson RH, Boshell BR. Severe hyponatremia associated with captopril therapy. Alabama Journal of Medical Sciences 21: 142\u2013144, 1984","journal-title":"Alabama Journal of Medical Sciences"},{"key":"BF03259832_CR99","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)91656-2","volume":"1","author":"CG Isles","year":"1983","unstructured":"Isles CG, Hodsman GP, Robertson JIS. Side-effects of captopril. Lancet 1: 355, 1983","journal-title":"Lancet"},{"key":"BF03259832_CR100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1620\/tjem.139.279","volume":"139","author":"Y Izumi","year":"1983","unstructured":"Izumi Y, Honda M, Hotano M, Kawahara Y. Influence of food on the clinical leffect of angiotensin I converting enzyme inhibitor (SQ14,225). Tohoku Journal of Experimental Medicine 139: 279\u2013286, 1983","journal-title":"Tohoku Journal of Experimental Medicine"},{"key":"BF03259832_CR101","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/00005344-198507001-00019","volume":"7","author":"AC Jenkins","year":"1985","unstructured":"Jenkins AC, Dreslinski GR, Tadros SS, Groel JT, Frand R, et al. Captopril in hypertension: seven years later. Journal of Cardiovascular Pharmacology 7: S96\u2013S101, 1985","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"BF03259832_CR102","first-page":"57S","volume":"48","author":"JG Johnson","year":"1975","unstructured":"Johnson JG, Black WD, Vukovich RA. Treatment of patients with severe hypertension by inhibition of angiotensin converting enzyme. Clinical Science and Molecular Medicine 48: 57S\u201360S, 1975","journal-title":"Clinical Science and Molecular Medicine"},{"key":"BF03259832_CR103","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1445-5994.1984.tb03632.x","volume":"14","author":"CI Johnston","year":"1984","unstructured":"Johnston CI. Treatment of hypertension with angiotensin converting enzyme inhibitors. Australian and New Zealand Journal of Medicine 14: 509\u2013513, 1984","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"BF03259832_CR104","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0140-6736(83)90377-X","volume":"2","author":"F Jorgensen","year":"1983","unstructured":"Jorgensen F, Badskjaer J, Nordin H. Captopril and resistant ascites. Lancet 2: 405, 1983","journal-title":"Lancet"},{"key":"BF03259832_CR105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/art.1780280528","volume":"28","author":"CG Kallenberg","year":"1985","unstructured":"Kallenberg CG. Autoantibodies during captopril treatment (correspondence). Arthritis and Rheumatism 28: 597\u2013598, 1985","journal-title":"Arthritis and Rheumatism"},{"key":"BF03259832_CR106","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/00365599.1984.11783725","volume":"79","author":"BE Karlberg","year":"1984","unstructured":"Karlberg BE, Fyhrquist F, Riska CG, Tikkanen I, Ohman KP. Enalapril and lisinopril in renovascular hypertension-anti-hypertensive and hormonal effects of two new angiotensin-converting enzyme (ACE) inhibitors. Scandinavian Journal of Urology and Nephrology 79 (Suppl.): 103\u2013106, 1984","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"key":"BF03259832_CR107","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-5347(17)53631-9","volume":"127","author":"J Kawakura","year":"1982","unstructured":"Kawakura J, Okada Y, Nishibuchi S, Yoshida D. Transient anuria following administration of angiotensin-I converting enzyme inhibitor (SQ14,225) in a patient with renal artery stenosis of the solitary kidney successfully treated with renal autotransplantation. Journal of Urology 127: 111\u20133, 1982","journal-title":"Journal of Urology"},{"key":"BF03259832_CR108","first-page":"213","volume":"306","author":"J Koch-Weser","year":"1982","unstructured":"Koch-Weser J. Captopril. New England Journal of Medicine 306: 213\u2013219, 1982","journal-title":"New England Journal of Medicine"},{"key":"BF03259832_CR109","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1161\/01.CIR.67.4.807","volume":"67","author":"BL Kramer","year":"1983","unstructured":"Kramer BL, Massie BM, Topic N. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study. Circulation 67: 807\u2013816, 1983","journal-title":"Circulation"},{"key":"BF03259832_CR110","doi-asserted-by":"crossref","first-page":"616","DOI":"10.7326\/0003-4819-100-4-616_1","volume":"100","author":"SH Kubo","year":"1984","unstructured":"Kubo SH, Cody RJ. Enalapril, a rash, and captopril. Annals of Internal Medicine 100: 616, 1984","journal-title":"Annals of Internal Medicine"},{"key":"BF03259832_CR111","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1445-5994.1984.tb03797.x","volume":"14","author":"B Leaker","year":"1984","unstructured":"Leaker B, Whitworth JA. Alopecia associated with captopril treatment. Australian and New Zealand Journal of Medicine 14: 866, 1984","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"BF03259832_CR112","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0002-8703(82)90045-X","volume":"104","author":"TB Levine","year":"1982","unstructured":"Levine TB, Cohn JN. Determination of acute and long-term response to converting enzyme inhibition in congestive heart failure. American Heart Journal 104: 1159\u201364, 1982","journal-title":"American Heart Journal"},{"key":"BF03259832_CR113","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/01.CIR.69.3.548","volume":"69","author":"TB Levine","year":"1984","unstructured":"Levine TB, Olivari MT, Garberg V, Sharkey SW, Cohn JN. Hemodynamic and clinical response to enalapril, a long-acting converting enzyme inhibiton, in patients with congestive heart failure. Circulation 69: 548\u2013553, 1984","journal-title":"Circulation"},{"key":"BF03259832_CR114","unstructured":"Lewis E. Angiotensin converting enzyme and the kidney, in press, 1986"},{"key":"BF03259832_CR115","first-page":"105","volume":"7","author":"EJ Lewis","year":"1982","unstructured":"Lewis EJ. Captopril Collaborative Study Group: proteinuria and abnormalities of the renal glomerulus in patients with hypertension. Clinical and Experimental Pharmacology and Physiology 7 (Suppl.): 105\u2013115, 1982","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"BF03259832_CR116","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jama.1984.03350070018012","volume":"250","author":"EJ Lewis","year":"1984","unstructured":"Lewis EJ. Captopril and membranous glomerulonephropathy. Journal of the American Medical Association 250: 900, 1984","journal-title":"Journal of the American Medical Association"},{"key":"BF03259832_CR117","unstructured":"Lewis EJ. Captopril and the kidney, in press, 1986"},{"key":"BF03259832_CR118","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365599.1984.11783724","volume":"79","author":"M Lindsjo","year":"1984","unstructured":"Lindsjo M, Danielson BG, Weiss L, Wikstrom B. Enalapril treatment in a patient with impaired renal function and intolerance to captopril. Scandinavian Journal of Urology and Nephrology 79: 99\u2013101, 1984","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"key":"BF03259832_CR119","first-page":"339","volume":"53","author":"HF Loyke","year":"1970","unstructured":"Loyke HF. Liver enzymes in hypertension. American Journal of Gastroenterology 53: 339\u2013351, 1970","journal-title":"American Journal of Gastroenterology"},{"key":"BF03259832_CR120","unstructured":"Mackeness G. The significance of captopril\u2019s sulfhydryl group. Symposium. Advances in cardiovascular disease, Bermuda, June 17, 1983"},{"key":"BF03259832_CR121","first-page":"626","volume":"22","author":"R Mantyl","year":"1984","unstructured":"Mantyl R, Mannisto PT, Vuorela A, Sundberg S, Ottoila P. Impairment of captopril bioavailability by concomitant food and antacid intake. Journal of Clinical Pharmacology 22: 626\u2013629, 1984","journal-title":"Journal of Clinical Pharmacology"},{"key":"BF03259832_CR122","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/art.1780221013","volume":"22","author":"JA Markenson","year":"1979","unstructured":"Markenson JA, Sherman RL. Renal involvement in progressive systemic sclerosis; prolonged survival with aggressive antihypertensive management. Arthritis Rheumatism 22: 1132\u20131134, 1979","journal-title":"Arthritis Rheumatism"},{"key":"BF03259832_CR123","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/bmj.286.6374.1350","volume":"286","author":"JC Mason","year":"1983","unstructured":"Mason JC, Hilton PJ. Repeated renal failure with use of captopril in a cystinotic renal allograft recipient. British Medical Journal 286: 145\u2013146, 1983","journal-title":"British Medical Journal"},{"key":"BF03259832_CR124","first-page":"277","volume":"283","author":"AE Matri","year":"1981","unstructured":"Matri AE, Larabi MS, Kechrid C, Belkahia C, Ayed HB. Fatal bone-marrow suppression associated with captopril. British Medical Journal 283: 277\u2013278, 1981","journal-title":"British Medical Journal"},{"key":"BF03259832_CR125","first-page":"314","volume":"22","author":"KS Matsuya","year":"1984","unstructured":"Matsuya KS, Ura T, Jodai A, Shimomae H, Hirose MKT, et al. Captopril-associated granulocytopenia in hypertension after renal transplantation. Clinical Nephrology 22: 314\u2013316, 1984","journal-title":"Clinical Nephrology"},{"key":"BF03259832_CR126","doi-asserted-by":"crossref","unstructured":"Mauersberger H, Witte PU. Disappearance of captopril-induced taste disturbance after substitution with ACE inhibitor HOE498. Lancet 517\u2013518, 1985","DOI":"10.1016\/S0140-6736(85)92115-4"},{"key":"BF03259832_CR127","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1440-1681.1980.tb00097.x","volume":"7","author":"BP McGrath","year":"1980","unstructured":"McGrath BP, Matthews PG, Johnston CI. Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients. Clinical and Experimental Pharmacology and Physiology 7: 487\u2013492, 1980","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"BF03259832_CR128","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/j.1552-4604.1982.tb02661.x","volume":"22","author":"DN McKinistry","year":"1982","unstructured":"McKinistry DN, Shaw JM, Willard DA, Misdalof BH. Effect of food on the bioavailability of captopril in healthy subjects. Journal of Clinical Pharmacology 22: 135\u2013140, 1982","journal-title":"Journal of Clinical Pharmacology"},{"key":"BF03259832_CR129","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/bmj.2.6204.1555-a","volume":"2","author":"JJ McNeil","year":"1979","unstructured":"McNeil JJ, Anderson A, Christophiidis N, Jarrott B, Louis WJ. Taste loss associated with captopril treatment. British Medical Journal 2: 1555\u20131556, 1979","journal-title":"British Medical Journal"},{"key":"BF03259832_CR130","first-page":"1091","volume":"75","author":"BL Mirkin","year":"1985","unstructured":"Mirkin BL, Newman TJ. Efficacy and safety of captopril in the treatment of severe childhood hypertension. Report of the International Collaborative Study Group. Pediatrics 75: 1091\u20131100, 1985","journal-title":"Report of the International Collaborative Study Group. Pediatrics"},{"key":"BF03259832_CR131","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/bmj.284.6312.310","volume":"284","author":"S Miyazaki","year":"1982","unstructured":"Miyazaki S, Miura K, Kasai V, Abe K, Yashinaga K. Relief from digital vasospasm by treatment with captopril and its complete inhibition by serine proteinase inhibitors in Raynaud\u2019s phenomenon. British Medical Journal 284: 310\u2013311, 1982","journal-title":"British Medical Journal"},{"issue":"1","key":"BF03259832_CR132","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2165\/00003495-198500301-00012","volume":"30","author":"F Moncloa","year":"1985","unstructured":"Moncloa F, Sromovsky JA, Walker JF, Davies RO. Enalapril in hypertension and congestive heart failure. Drugs 30 (Suppl. 1): 82\u201389, 1985","journal-title":"Drugs"},{"key":"BF03259832_CR133","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0002-8703(83)90286-7","volume":"105","author":"S Mookerjee","year":"1983","unstructured":"Mookerjee S, Anderson Jr GH, Eich R, Hill N, Smulyan H, et al. Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension. American Heart Journal 105: 106\u2013112, 1983","journal-title":"American Heart Journal"},{"key":"BF03259832_CR134","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/hrt.52.1.63","volume":"52","author":"SK Mujais","year":"1984","unstructured":"Mujais SK, Fouad FM, Textor SC, Tarazi RC, Bravo EL, et al. Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure. British Heart Journal 52: 63\u201371, 1984","journal-title":"British Heart Journal"},{"key":"BF03259832_CR135","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bmj.288.6420.844","volume":"288","author":"BF Murphy","year":"1984","unstructured":"Murphy BF, Whitworth JA, Kincaid-Smith P. Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics. British Medical Journal 288: 844\u2013845, 1984","journal-title":"British Medical Journal"},{"key":"BF03259832_CR136","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0002-9343(85)90030-0","volume":"79","author":"AP Niarchos","year":"1985","unstructured":"Niarchos AP, Resnick LM, Weinstein DL, Laragh JH. Angiotensin I converting enzyme activity in hypertension. American Journal of Medicine 79: 435, 1985","journal-title":"American Journal of Medicine"},{"key":"BF03259832_CR137","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/0002-9149(82)90367-8","volume":"49","author":"MG Nicholls","year":"1982","unstructured":"Nicholls MG, Ikram H, Espiner EA, Maslowski AH, Scandrett MS, et al. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies. American Journal of Cardiology 49: 1497\u20131501, 1982","journal-title":"American Journal of Cardiology"},{"key":"BF03259832_CR138","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/bmj.281.6245.909","volume":"281","author":"MG Nicolls","year":"1980","unstructured":"Nicolls MG, Espiner EA, Ikram H, Maslowski AH. Hyponatremia and congestive heart failure during treatment with captopril. British Medical Journal 281: 909\u2013912, 1980","journal-title":"British Medical Journal"},{"key":"BF03259832_CR139","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/00005344-198507001-00005","volume":"7","author":"KP Ohman","year":"1985","unstructured":"Ohman KP, Kagedal B, Larsson R, Karlberg BE. Pharmacokinetics of captopril and its effect on blood pressure during acute and chronic administration and in relation to food intake. Journal of Cardiovascular Pharmacology 7: S20\u2013S24, 1985","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"BF03259832_CR140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.HYP.5.2.166","volume":"5","author":"JA Oliver","year":"1983","unstructured":"Oliver JA, Sciacca RR, Cannon PJ. Renal vasodilation by converting enzyme inhibition: role of renal prostaglandins. Hypertension 5: 166\u2013171, 1983","journal-title":"Hypertension"},{"key":"BF03259832_CR141","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1126\/science.191908","volume":"196","author":"MA Ondetti","year":"1977","unstructured":"Ondetti MA, Rubin B, Cushman DW, Cheung HS, Sabo EF. Design of specific inhibitors of angiotensin converting enzyme: new class of orally active antihypertensive agents. Science 196: 441\u2013444, 1977","journal-title":"Science"},{"key":"BF03259832_CR142","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1021\/bi00798a004","volume":"10","author":"MA Ondetti","year":"1971","unstructured":"Ondetti MA, Williams NJ, Sabo EF, Pluscec J, Weaver ER, et al. Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca: isolation, elucidation of structure and synthesis. Biochemistry 10: 4033\u20134039, 1971","journal-title":"Biochemistry"},{"key":"BF03259832_CR143","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7326\/0003-4819-104-2-147","volume":"104","author":"M Packer","year":"1986","unstructured":"Packer M, Lee WH, Medina N, Yushak M. Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure. Annals of Internal Medicine 104: 147\u2013154, 1986","journal-title":"Annals of Internal Medicine"},{"key":"BF03259832_CR144","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0735-1097(85)80125-X","volume":"6","author":"M Packer","year":"1985","unstructured":"Packer M, Lee WH, Medina N, Yushak M. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe heart chronic heart failure. Journal of the American College of Pharmacology 6: 635\u2013645, 1985","journal-title":"Journal of the American College of Pharmacology"},{"key":"BF03259832_CR145","doi-asserted-by":"crossref","first-page":"782","DOI":"10.7326\/0003-4819-100-6-782","volume":"100","author":"M Packer","year":"1984","unstructured":"Packer M, Medina N, Yushak M. Correction of dilutional hyponatremia in severe chronic heart failure by converting enzyme inhibition. Annals of Internal Medicine 100: 782\u2013789, 1984","journal-title":"Annals of Internal Medicine"},{"key":"BF03259832_CR146","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.CIR.68.4.803","volume":"68","author":"M Packer","year":"1983","unstructured":"Packer M, Medina N, Yushak M, Meller J. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. Circulation 68: 803\u2013812, 1983","journal-title":"Circulation"},{"key":"BF03259832_CR147","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(84)91807-5","volume":"1","author":"DJ Pennell","year":"1984","unstructured":"Pennell DJ, Nunan TO, O\u2019Doherty MJ, Croft DN. Fatal Stevens-Johnson Syndrome in a patient on captopril and allopurinol. Lancet 1: 463, 1984","journal-title":"Lancet"},{"key":"BF03259832_CR148","doi-asserted-by":"crossref","unstructured":"Pipkin FB, Turner SR, Symonds EM. Possible risk with captopril in pregnancy; some animal data. Lancet (June 7): 1256, 1980","DOI":"10.1016\/S0140-6736(80)91723-7"},{"key":"BF03259832_CR149","first-page":"665","volume":"309","author":"Y Pirson","year":"1983","unstructured":"Pirson Y, De Meyer M, De Plaen JF, Squifflet JP, Alexandre GP. Captopril and renal insufficiency. New England Journal of Medicine 309: 665\u2013667, 1983","journal-title":"New England Journal of Medicine"},{"key":"BF03259832_CR150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.7326\/0003-4819-102-1-56","volume":"102","author":"J Rahmat","year":"1985","unstructured":"Rahmat J, Gelfand RL, Gelfand MC, Winchester JF, Schreiner GE, et al. Captopril-associated cholestatic jaundice. Annals of Internal Medicine 102: 56\u201358, 1985","journal-title":"Annals of Internal Medicine"},{"key":"BF03259832_CR151","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0002-9149(82)90363-0","volume":"49","author":"AEG Raine","year":"1982","unstructured":"Raine AEG, Ledingham JGG. Clinical experience with captopril in the treatment of drug resistant hypertension. American Journal of Cardiology 49: 1475\u20131479, 1982","journal-title":"American Journal of Cardiology"},{"key":"BF03259832_CR152","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(84)90891-X","volume":"76","author":"B Rajagopalan","year":"1984","unstructured":"Rajagopalan B, Raine AEG, Cooper R, Ledingham JGG. Changes in cerebral blood flow in patients with severe congestive heart failure before and after captopril. American Journal of Medicine 76: 86\u201390, 1984","journal-title":"American Journal of Medicine"},{"key":"BF03259832_CR153","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/archinte.1982.00340180072016","volume":"142","author":"CVS Ram","year":"1982","unstructured":"Ram CVS. Captopril. Archives of Internal Medicine 142: 914\u2013916, 1982","journal-title":"Archives of Internal Medicine"},{"key":"BF03259832_CR154","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000409951","volume":"43","author":"FC Reubi","year":"1984","unstructured":"Reubi FC. Captopril and renal function. Contributions to Nephrology 43: 159\u2013170, 1984","journal-title":"Contributions to Nephrology"},{"key":"BF03259832_CR155","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/art.1780270516","volume":"27","author":"MM Reidenberg","year":"1984","unstructured":"Reidenberg MM, Case DB, Drayer DE, Reir S, Lorenzo B. Development of antinuclear antibody in patients treated with high doses of captopril. Arthritis and Rheumatism 27: 579\u2013581, 1984","journal-title":"Arthritis and Rheumatism"},{"key":"BF03259832_CR156","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(83)90148-4","volume":"2","author":"T Ring","year":"1983","unstructured":"Ring T. Captopril and resistant ascites; a word of caution. Lancet 2: 165, 1983","journal-title":"Lancet"},{"key":"BF03259832_CR157","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2165\/00003495-198325010-00002","volume":"25","author":"JA Romankiewicz","year":"1983","unstructured":"Romankiewicz JA, Brogden RN, Heel RC, Speight TM, Avery GS. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure. Drugs 25: 6\u201340, 1983","journal-title":"Drugs"},{"key":"BF03259832_CR158","first-page":"282","volume":"27","author":"AJ Rommel","year":"1980","unstructured":"Rommel AJ, Pierides AM, Heald A. Captopril elimination in chronic renal failure. Clinical Pharmacology and Therapeutics 27: 282, 1980","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259832_CR159","first-page":"172","volume":"2","author":"C Rosendorff","year":"1980","unstructured":"Rosendorff C, Milne FJ, Levy H, Ninin DT, Lewin JR. Nephrotic syndrome during captopril therapy. South African Medical Journal 2: 172\u2013173, 1980","journal-title":"South African Medical Journal"},{"key":"BF03259832_CR160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/j.1875-9114.1983.tb04549.x","volume":"3","author":"HH Rotmensch","year":"1983","unstructured":"Rotmensch HH, Vlasses PH, Ferguson RK. Resolution of captopril-induced rash after substitution of enalapril. Pharmacotherapy 3: 131\u2013133, 1983","journal-title":"Pharmacotherapy"},{"key":"BF03259832_CR161","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0033-0620(78)90024-5","volume":"21","author":"B Rubin","year":"1978","unstructured":"Rubin B, Antonaccio MJ, Horovitz ZP. Captopril, SQ 14,225 (D-3 mercapto-2-methyl propranoyl-L-proline): a new orally active inhibitor of angiotensin converting enzyme and antihypertensive agent. Progress in Cardiovascular Diseases 21: 183\u2013194, 1978a","journal-title":"Progress in Cardiovascular Diseases"},{"key":"BF03259832_CR162","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3565(25)31139-0","volume":"204","author":"B Rubin","year":"1978","unstructured":"Rubin B, Laffen RJ, Kotler DG, O\u2019Keefe EH, De Maio DA, et al. SQ14,225 (D-3 mercapto-2-methyl propanoyl-L-proline): a novel orally active inhibitor of angiotensin-I-converting enzyme. Journal of Pharmacology and Experimental Therapeuticcs 204: 271\u2013280, 1978b","journal-title":"Journal of Pharmacology and Experimental Therapeuticcs"},{"key":"BF03259832_CR163","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/bmj.286.6372.1192","volume":"286","author":"PC Rubin","year":"1983","unstructured":"Rubin PC, Reid JL. Alpha blockers and converting enzyme inhibitors. British Medical Journal 286: 1192\u20131195, 1983","journal-title":"British Medical Journal"},{"key":"BF03259832_CR164","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/bmj.283.6294.791-b","volume":"283","author":"ME Safar","year":"1981","unstructured":"Safar ME. Fatal bone-marrow suppression associated with captopril. British Medical Journal 283: 791\u2013792, 1981","journal-title":"British Medical Journal"},{"key":"BF03259832_CR165","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/00005344-198507001-00006","volume":"7","author":"A Salvetti","year":"1985","unstructured":"Salvetti A, Pedrinelli R, Magagna A, Abdel-Haq B, Graziadei L, et al. Influence of food on acute and chronic effects of captopril in essential hypertensive patients. Journal of Cardiovascular Pharmacology 7: S25\u2013S29, 1985","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"BF03259832_CR166","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000409953","volume":"43","author":"RM Schaefer","year":"1984","unstructured":"Schaefer RM, Heidland A. Captopril: indications and clinical problems. Contributions to Nephrology 43: 182\u2013203, 1984","journal-title":"Contributions to Nephrology"},{"key":"BF03259832_CR167","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(84)91809-9","volume":"1","author":"MADH Schalekamp","year":"1984","unstructured":"Schalekamp MADH, Wenting GJ. Angiotensin converting enzyme inhibition in renovascular hypertension: failure of the stenotic kidney. Lancet 1: 464, 1984","journal-title":"Lancet"},{"key":"BF03259832_CR168","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.1983.03340010017009","volume":"250","author":"MJ Schreiber Jr","year":"1983","unstructured":"Schreiber Jr MJ, Fang LS. Renal failure associated with captopril. Journal of the American Medical Association, 250: 31, 1983","journal-title":"Journal of the American Medical Association"},{"key":"BF03259832_CR169","first-page":"390","volume":"2","author":"YK Seedat","year":"1980","unstructured":"Seedat YK. Nephrotic syndrome from captopril. South African Medical Journal 2: 390, 1980","journal-title":"South African Medical Journal"},{"key":"BF03259832_CR170","first-page":"61","volume":"314","author":"PF Semple","year":"1986","unstructured":"Semple PF, Herd GW. Cough and wheeze caused by inhibitors of angiotensin converting enzyme. New England Journal of Medicine 314: 61, 1986","journal-title":"New England Journal of Medicine"},{"key":"BF03259832_CR171","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archinte.1985.00360080206033","volume":"145","author":"S Sesoko","year":"1985","unstructured":"Sesoko S, Kaneko Y. Cough associated with the use of captopril. Archives of Internal Medicine 145: 1524, 1985","journal-title":"Archives of Internal Medicine"},{"key":"BF03259832_CR172","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(83)92181-5","volume":"1","author":"AN Shepherd","year":"1983","unstructured":"Shepherd AN, Neligan P, Hayes PC. Captopril and resistant ascites. Lancet 1: 1391\u20131392, 1983","journal-title":"Lancet"},{"key":"BF03259832_CR173","first-page":"1141","volume":"156B","author":"F Sicuteri","year":"1983","unstructured":"Sicuteri F. Inhibition of peptidase degrading endogenous opiods: a new trend in the management of migraine and correlated \u2018pain diseases\u2019. Advances in Experimental Medicine and Biology 156B: 1141\u20131151, 1983","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"BF03259832_CR174","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1136\/bmj.286.6379.1702-a","volume":"286","author":"JH Silas","year":"1983","unstructured":"Silas JH, Klenka Z, Solomon SA. Captopril induced reversible renal failure: a marker of renal artery stenosis affecting a solitary kidney. British Medical Journal 286: 1702\u20131703, 1983","journal-title":"British Medical Journal"},{"key":"BF03259832_CR175","first-page":"875","volume":"14","author":"K Silberbauer","year":"1982","unstructured":"Silberbauer K, Stanek B, Tempi H. Acute hypotensive effect on captopril in man modified by prostaglandin synthesis inhibition. British Journal of Clinical Pharmacology 14: 875\u2013965, 1982","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259832_CR176","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/clpt.1982.145","volume":"32","author":"SM Singhui","year":"1982","unstructured":"Singhui SM, Duchin KL, Willard DA. Renal handling of captopril: effect of probenecid. Clinical Pharmacology and Therapeutics 32: 182\u2013189, 1982","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259832_CR177","first-page":"23","volume":"28","author":"AJ Smit","year":"1985","unstructured":"Smit AJ, Hoorntje JJ, Weening AJM, Donker AJM, Hoedemaeker PJ. Unilateral membranous glomerulopathy during captopril treatment. Netherlands Journal of Medicine 28: 23\u201327, 1985","journal-title":"Netherlands Journal of Medicine"},{"key":"BF03259832_CR178","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2222.1984.tb02224.x","volume":"14","author":"AJ Smit","year":"1984","unstructured":"Smit AJ, Van Der Laan S, De Monchy J, Kallenberg CGM, Donker AJM. Cutaneous reactions to captopril. Clinical Allergy 14: 413\u2013419, 1984","journal-title":"Clinical Allergy"},{"issue":"2","key":"BF03259832_CR179","first-page":"113","volume":"2","author":"WM Smith","year":"1984","unstructured":"Smith WM, Kulaga SF, Pingeon MR, Walker JF. Overall tolerance and safety of enalapril. Journal of Hypertension 2 (Suppl. 2): 113\u2013117, 1984a","journal-title":"Journal of Hypertension"},{"key":"BF03259832_CR180","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/art.1780270716","volume":"27","author":"CD Smith","year":"1984","unstructured":"Smith CD, Smith RD, Korn JH. Hypertensive crisis in systemic sclerosis: treat with the new oral angiotensin converting enzyme inhibitor MK421 (Enalapril) in captopril-intolerant patients. Arthritis and Rheumatism 27: 826\u2013829, 1984b","journal-title":"Arthritis and Rheumatism"},{"key":"BF03259832_CR181","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1365-2125.1984.tb02520.x","volume":"18","author":"WM Smith","year":"1984","unstructured":"Smith WM, Davies RO, Gabriel MA, Kramsch DM, Moncloa F, et al. Tolerance and safety of enalapril. British Journal of Clinical Pharmacology 18: 2495\u20132535, 1984c","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259832_CR182","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(80)90853-3","volume":"1","author":"J Staessen","year":"1980","unstructured":"Staessen J, Fagard R, Lijnen P, Amery A. Captopril and agranulocytosis. Lancet 1: 926\u2013827, 1980","journal-title":"Lancet"},{"key":"BF03259832_CR183","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0002-9343(83)91180-4","volume":"75","author":"TI Steinman","year":"1983","unstructured":"Steinman TI, Silva P. Acute renal failure, skin rash and eosinophilia associated with captopril therapy. American Journal of Medicine 75: 154\u2013156, 1983","journal-title":"American Journal of Medicine"},{"key":"BF03259832_CR184","first-page":"320","volume":"132","author":"RK Strair","year":"1985","unstructured":"Strair RK, Mitch WE, Faller DV, Skorecki KL. Reversible captopril associated bone-marrow aplasia. Canadian Medical Association Journal 132: 320\u2013322, 1985","journal-title":"Canadian Medical Association Journal"},{"key":"BF03259832_CR185","first-page":"11","volume":"10","author":"KO Stumpe","year":"1984","unstructured":"Stumpe KO, Kolloch R, Overlack A. Captopril and enalapril: evaluation of therapeutic efficacy and safety. Practical Cardiology 10: 11\u2013124, 1984","journal-title":"Practical Cardiology"},{"key":"BF03259832_CR186","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/jama.1983.03340170069032","volume":"250","author":"BC Sturgill","year":"1983","unstructured":"Sturgill BC, Shearlock KT. Membranous glomerulopathy and nephrotic syndrome after captopril therapy. Journal of the American Medical Association 250: 2343\u20132345, 1983","journal-title":"Journal of the American Medical Association"},{"key":"BF03259832_CR187","first-page":"320","volume":"132","author":"RK Strair","year":"1985","unstructured":"Strair RK, Mitch WE, Faller DV, Skorecki KL. Reversible captopril associated bone-marrow aplasia. Canadian Medical Association Journal 132: 320\u2013322, 1985","journal-title":"Canadian Medical Association Journal"},{"key":"BF03259832_CR188","first-page":"11","volume":"10","author":"KO Stumpe","year":"1984","unstructured":"Stumpe KO, Kolloch R, Overlack A. Captopril and enalapril: evaluation of therapeutic efficacy and safety. Practical Cardiology 10: 11\u2013124, 1984","journal-title":"Practical Cardiology"},{"key":"BF03259832_CR189","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/jama.1983.03340170069032","volume":"250","author":"BC Sturgill","year":"1983","unstructured":"Sturgill BC, Shearlock KT. Membranous glomerulopathy and nephrotic syndrome after captopril therapy. Journal of the American Medical Association 250: 2343\u20132345, 1983","journal-title":"Journal of the American Medical Association"},{"key":"BF03259832_CR190","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/00007611-198310000-00024","volume":"76","author":"S Sunderrajan","year":"1983","unstructured":"Sunderrajan S, Luger A, Bauer JH. Captopril-induced membranous glomerulonephropathy. Southern Medical Journal 76: 1294\u20131296, 1983","journal-title":"Southern Medical Journal"},{"key":"BF03259832_CR191","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.HYP.1.2.106","volume":"1","author":"SL Swartz","year":"1979","unstructured":"Swartz SL, Williams GH, Hollenberg NK, Moore TJ, Dlugy RG. Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation. Hypertension 1: 106, 1979","journal-title":"Hypertension"},{"key":"BF03259832_CR192","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198512263132601","volume":"313","author":"Y Taguma","year":"1985","unstructured":"Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H. Effect of captopril on heavy proteinuria in azotemic diabetes. New England Journal of Medicine 313: 1617\u20131620, 1985 au]Tempero KF, Kramsch DM, Moncloa F. The safety profile of enalapril. Proceedings of the XVII International Congress of Therapy, Rome, Italy, Sept 27\u201330, 1983","journal-title":"New England Journal of Medicine"},{"key":"BF03259832_CR193","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0002-9343(82)90415-6","volume":"73","author":"SC Textor","year":"1982","unstructured":"Textor SC, Bavo EL, Fouad FM, Tarazi RC. Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and alodsterone reduction with captopril. American Journal of Medicine 73: 719\u2013725, 1982","journal-title":"American Journal of Medicine"},{"key":"BF03259832_CR194","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0002-9343(83)91031-8","volume":"74","author":"SC Textor","year":"1983","unstructured":"Textor SC, Gephardt GN, Bravo EL, Tarazi RC, Fouad FM, Tubbs R, McMahon JT. Membranous glomerulopathy associated with captopril therapy. American Journal of Medicine 74: 705\u2013712, 1983","journal-title":"American Journal of Medicine"},{"key":"BF03259832_CR195","doi-asserted-by":"crossref","first-page":"308","DOI":"10.7326\/0003-4819-102-3-308","volume":"102","author":"SC Textor","year":"1985","unstructured":"Textor SC, Novick AC, Tarazi RC, Klimas V, Vidt DG, et al. Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vasculr disease. Annals of Internal Medicine 102: 308\u2013314, 1985","journal-title":"Annals of Internal Medicine"},{"key":"BF03259832_CR196","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9343(84)90880-5","volume":"76","author":"SC Textor","year":"1984","unstructured":"Textor SC, Tarazi RC, Novick AC, Bravo EL, Fouad FM. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during coverting enzyme inhibition with captopril. American Journal of Medicine (Suppl. 5B) 76: 29\u201337, 1984","journal-title":"American Journal of Medicine (Suppl. 5B)"},{"key":"BF03259832_CR197","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0002-8703(85)90650-7","volume":"109","author":"GS Thind","year":"1985","unstructured":"Thind GS, Johnson A, Bhatnager D, Henkel TW. A parallel study of enalapril and captopril and 1 year of experience with enalapril treatment in moderate to severe hypertension. American Heart Journal 109: 852\u2013858, 1985","journal-title":"American Heart Journal"},{"key":"BF03259832_CR198","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archinte.1984.00350160083015","volume":"144","author":"RH Thurm","year":"1984","unstructured":"Thurm RH, Alexander JC. Captopril in the treatment of scleroderma renal crisis. Archives of Internal Medicine 144: 733\u2013735, 1984","journal-title":"Archives of Internal Medicine"},{"key":"BF03259832_CR199","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(79)91897-X","volume":"1","author":"GA Turini","year":"1979","unstructured":"Turini GA, Brunner HR, Gribic M, Waeber B, Gavras H. Improvement of chronic heart failure by oral captopril. Lancet 1: 1213\u20131215, 1979","journal-title":"Lancet"},{"key":"BF03259832_CR200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(80)90629-7","volume":"1","author":"P Brummelen Van","year":"1980","unstructured":"Van Brummelen P, Willemze R, Tan WD, Thompson J. Captopril-associated agranulocytosis. Lancet 1: 150, 1980","journal-title":"Lancet"},{"key":"BF03259832_CR201","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2125.1981.tb01116.x","volume":"11","author":"M Vandenburg","year":"1981","unstructured":"Vandenburg M, Parfrey P, Wright P, Lazda E. Hepatitis associated with captopril treatment. British Journal of Clinical Pharmacology 11: 105\u2013106, 1981","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259832_CR202","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000183369","volume":"39","author":"FJ Woude van der","year":"1985","unstructured":"van der Woude FJ, van Son WJ, Tegzess AM, Donker AJM, Sloof MJH, et al. Effect of captopril on blood pressure and renal function in patients with transplant renal artery stenosis. Nephron 39: 184\u2013188, 1985","journal-title":"Nephron"},{"key":"BF03259832_CR203","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/bmj.289.6436.20","volume":"289","author":"DL Verbeelen","year":"1984","unstructured":"Verbeelen DL, De Boel S. Reversible acute on chronic renal failure during captopril treatment. British Medical Journal 289: 20\u201321, 1984","journal-title":"British Medical Journal"},{"key":"BF03259832_CR204","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/archinte.1984.04400010055010","volume":"144","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents.","year":"1984","unstructured":"Veterans Administration Cooperative Study Group on Antihypertensive Agents. Low dose captopril for the treatment of mild to moderate hypertension. Archives of Internal Medicine 144: 1947\u20131953, 1984","journal-title":"Archives of Internal Medicine"},{"key":"BF03259832_CR205","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM198201283060405","volume":"306","author":"DG Vidt","year":"1982","unstructured":"Vidt DG, Bravo EL, Fouad FM. Drug therapy: captopril. New England Journal of Medicine 306: 214\u2013219, 1982","journal-title":"New England Journal of Medicine"},{"key":"BF03259832_CR206","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/archderm.1982.01650240003001","volume":"118","author":"R Viraben","year":"1982","unstructured":"Viraben R, Adoue D, Dupre A, Touron P. Erosions and ulcers of the mouth. Archives of Dermatology 118: 959, 1982","journal-title":"Archives of Dermatology"},{"key":"BF03259832_CR207","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(79)91579-4","volume":"2","author":"PH Vlasses","year":"1979","unstructured":"Vlasses PH, Ferguson RK. Temporary ageusia related to captopril. Lancet 2: 526, 1979","journal-title":"Lancet"},{"key":"BF03259832_CR208","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/j.1552-4604.1983.tb02729.x","volume":"23","author":"PH Vlasses","year":"1983","unstructured":"Vlasses PH, Rotmensch HH, Swanson BN, Irving JD, Lee RB, et al. Comparative antihypertensive effects of enalapril maleate and HCTZ, alone and in combination. Journal of Clinical Pharmacology 23: 227\u2013233, 1983","journal-title":"Journal of Clinical Pharmacology"},{"key":"BF03259832_CR209","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archinte.1982.00340190054010","volume":"142","author":"PH Vlasses","year":"1982","unstructured":"Vlasses PH, Rotmensch HH, Swanson BN, Mojaverian P, Ferguson RK. Low dose captopril: its use in mild to moderate hypertension unresponsive to diuretic treatment. Archives of Internal Medicine 142: 1098\u20131101, 1982","journal-title":"Archives of Internal Medicine"},{"key":"BF03259832_CR210","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.1980.03310220049028","volume":"244","author":"SE Warren","year":"1980","unstructured":"Warren SE, O\u2019Connor DT. Hyperkalemia resulting from captopril administration. Journal of the American Medical Association 244: 2551\u20132552, 1980","journal-title":"Journal of the American Medical Association"},{"key":"BF03259832_CR211","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1445-5994.1981.tb03744.x","volume":"11","author":"MA Watson","year":"1981","unstructured":"Watson MA, Radford NJ, McGrath BP, et al. Captopril-induced agranulocytosis in systemic sclerosis. Australian and New Zealand Journal of Medicine 11: 79\u201381, 1981","journal-title":"Australian and New Zealand Journal of Medicine"},{"issue":"2","key":"BF03259832_CR212","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2125.1982.tb02069.x","volume":"14","author":"MH Weinberger","year":"1982","unstructured":"Weinberger MH. Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate hypertension. British Journal of Clinical Pharmacology 14 (Suppl. 2): 127\u2013131, 1982","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259832_CR213","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/bmj.288.6421.886","volume":"288","author":"GJ Wenting","year":"1984","unstructured":"Wenting GJ, Tan-Tjiong HL, Derkx FH, de Bruyn JH, Man in\u2019T Veld AJ, et al. Split renal function after captopril in unilateral renal artery stenosis. British Medical Journal 288: 886\u2013890, 1984","journal-title":"British Medical Journal"},{"key":"BF03259832_CR214","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/art.1780250301","volume":"25","author":"HH Whiteman","year":"1982","unstructured":"Whiteman HH, Case DB, Laragh JH, Christian Cl, Botstein G, et al. Variable response to oral angiotensin converting enzyme blockade in hypertensive scleroderma patients. Arthritis and Rheumatism 25: 241\u2013248, 1982","journal-title":"Arthritis and Rheumatism"},{"key":"BF03259832_CR215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(80)90002-1","volume":"2","author":"NJ White","year":"1980","unstructured":"White NJ, Rajagopalan B, Yahaya H, Ledingham JGG. Captopril and furosemide in severe drug-resistant hypertension. Lancet 2: 108\u2013110, 1980","journal-title":"Lancet"},{"key":"BF03259832_CR216","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1445-5994.1982.tb03821.x","volume":"12","author":"JA Whitworth","year":"1982","unstructured":"Whitworth JA, Walter NMA, Kincaid-Smith P. First dose effect of captopril. Australian and New Zealand Journal of Medicine 12: 325\u2013326, 1982","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"BF03259832_CR217","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archderm.1980.01640320052013","volume":"116","author":"JK Wilkin","year":"1980","unstructured":"Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. Archives of Dermatology 116: 902\u2013905, 1980","journal-title":"Archives of Dermatology"},{"key":"BF03259832_CR218","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archderm.1982.01650150048022","volume":"118","author":"JK Wilkin","year":"1982","unstructured":"Wilkin JK, Kirkendall WM. Pityriasis rosea-like rash from captopril. Archives of Dermatology 118: 186\u2013187, 1982","journal-title":"Archives of Dermatology"},{"key":"BF03259832_CR219","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/pgmj.60.706.561","volume":"60","author":"PS Williams","year":"1984","unstructured":"Williams PS, Hendy MS, Ackrill R. Captopril-induced acute renal artery thrombosis and persistent anuria in a patient with documented pre-existing renal artery stenosis and renal failure. Postgraduate Medical Journal 60: 561\u2013563, 1984","journal-title":"Postgraduate Medical Journal"},{"key":"BF03259832_CR220","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/bmj.2.6198.1146-d","volume":"2","author":"K Woodhouse","year":"1979","unstructured":"Woodhouse K, Farrow PR, Wilkinson R. Reversible renal failure during treatment with captopril. British medical Journal 2: 1146\u20131147, 1979","journal-title":"British medical Journal"},{"key":"BF03259832_CR221","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1136\/bmj.287.6406.1676","volume":"287","author":"A Zimran","year":"1983","unstructured":"Zimran A, Abraham AS, Hershko C. Reversible cholestatic jaundice and hyperamylassemia associated with captopril treatment. British Medical Journal 287: 1676, 1983","journal-title":"British Medical Journal"},{"key":"BF03259832_CR222","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/ki.1984.119","volume":"25","author":"RM Zusman","year":"1984","unstructured":"Zusman RM. Renin-and non-renin-mediated antihypertensive actions of converting enzyme inhibitors. Kidney International 25: 969\u2013983, 1984","journal-title":"Kidney International"}],"container-title":["Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259832\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T09:52:32Z","timestamp":1748771552000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,4]]},"references-count":222,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986,4]]}},"alternative-id":["BF03259832"],"URL":"https:\/\/doi.org\/10.1007\/bf03259832","relation":{},"ISSN":["0112-5966"],"issn-type":[{"value":"0112-5966","type":"print"}],"subject":[],"published":{"date-parts":[[1986,4]]}}}